Supernus Pharmaceuticals, Inc. (LON:0LB2)
London · Delayed Price · Currency is GBP · Price in USD 51.80
+0.29 (0.56%)
At close: Dec 24, 2025
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of 2.19 billion as of December 26, 2025. Its market cap has increased by 37.77% in one year.
Market Cap
2.19B
Enterprise Value
2.02B
Revenue
507.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.80
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 2.19B, an increase of 2,669.62%. That is a compound annual growth rate of 27.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 2.19B | 37.48% |
| Dec 31, 2024 | 1.59B | 28.49% |
| Dec 29, 2023 | 1.24B | -22.44% |
| Dec 30, 2022 | 1.60B | 39.74% |
| Dec 31, 2021 | 1.15B | 17.96% |
| Dec 31, 2020 | 970.89M | 3.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| GSK plc | 72.45B |
| Haleon | 33.16B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.71B |
| HUTCHMED (China) | 1.69B |